Skip links

Archive

MiniVax, Inc. and University of Rochester Enter into Option for Antibody Treatment against Pneumocystis pneumonia

MiniVax, Inc. and University of Rochester Enter into Option for Antibody Treatment against Pneumocystis pneumonia

in

NEW ORLEANS & ROCHESTER, N.Y.–(BUSINESS WIRE)–MiniVax, Inc. (New Orleans, LA) and the University of Rochester (Rochester, NY) announce that they have entered into an exclusive option agreement with agreed licensing terms to develop a monoclonal antibody for the treatment of Pneumocystis pneumonia (PCP). The antibody